Financial Statements - Solvay
Financial Statements - Solvay
Financial Statements - Solvay
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
future) reacts with atmospheric<br />
oxygen in an electrochemical<br />
reaction (the reverse of electrolysis);<br />
developing hydrogen storage<br />
solutions by investing on the<br />
Conduit Ventures Fund (UK).<br />
In the fi eld of hydrogen-based<br />
energy production, <strong>Solvay</strong> Solexis is<br />
developing AQUIVION perfl uorinated<br />
proton exchange membranes<br />
for PEMFCs (Proton Exchange<br />
Membrane Fuel Cells).<br />
For its part, the SolviCore 50/50 joint<br />
venture with Umicore is developing<br />
and manufacturing on a pilot scale<br />
membrane-electrode assemblies<br />
(MEAs) that combine <strong>Solvay</strong>’s<br />
expertise in membrane polymers with<br />
Umicore’s in precious metals used as<br />
catalysts. SolviCore maintains close<br />
contacts with certain players in the<br />
hydrogen and fuel cells chain.<br />
At the end of 2008, <strong>Solvay</strong> invested<br />
GBP 1.25 million in ACAL Energy<br />
(UK), which is developing an original<br />
fuel cell concept in which the platinum<br />
cathode is replaced with a circulating<br />
of an aqueous solution of a more<br />
stable and less expensive liquid<br />
catalyst.<br />
The Nanotechnologies<br />
platform<br />
These technologies for structuring<br />
the infi nitely small have at times<br />
already led to specifi c products.<br />
Examples include the development<br />
and marketing of nanostructured<br />
fl uorinated polymers and the launch<br />
of NANOLIPANTHYL ® , a new<br />
formulation of an existing drug that<br />
facilitates assimilation.<br />
The platform was launched in mid-<br />
2008 with the mission of gathering,<br />
constructing and disseminating<br />
expertise in a multidisciplinary<br />
context, fi nding and supporting<br />
specifi c projects, and undertaking<br />
a scientifi c and technology watch in<br />
nanotechnologies. Four programs<br />
were activated in 2008.<br />
The Renewable Chemistry<br />
and Industrial Biotechnology<br />
platform<br />
This new platform has the mission<br />
of exploring <strong>Solvay</strong>’s development<br />
potential in these fi elds. It will also<br />
cover the different “renewable<br />
materials” chains. The fi rst concrete<br />
results in this area are the production<br />
of epichlorohydrin by the EPICEROL ®<br />
process and the project for a fi rst<br />
ethanol-based ethylene unit for PVC<br />
production in Brazil.<br />
For Renewable Chemistry, an initial<br />
series of partnerships were put<br />
together in 2008:<br />
membership in Europabio,<br />
the European Association for<br />
Bioindustries;<br />
participation in ACDV (Association<br />
Chimie du Végétal), a joint<br />
partnership in France between<br />
the UIC (Union des Industries<br />
Chimiques) and the corresponding<br />
agricultural industries;<br />
New Business Development<br />
participation in the BioHub program<br />
in France, which is subsidized by<br />
the AII (Agence de l’Innovation<br />
Industrielle);<br />
participation in the Eureka-labelled<br />
Halobios Plastici project, with<br />
French start-up SeaDev;<br />
investment in Capricorn Cleantech<br />
Fund, at Leuven (Belgium).<br />
47<br />
<strong>Solvay</strong> Global Annual Report 2008<br />
New Business Development